Steven R. Pacelli - Apr 27, 2023 Form 4 Insider Report for DEXCOM INC (DXCM)

Role
EVP Managing Director Dexcom V
Signature
By: Jereme Sylvain For: Steven Pacelli
Stock symbol
DXCM
Transactions as of
Apr 27, 2023
Transactions value $
-$633,906
Form type
4
Date filed
4/27/2023, 06:38 PM
Previous filing
Apr 26, 2023
Next filing
May 23, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DXCM Common Stock Sale -$634K -5.03K -3.65% $126.00 133K Apr 27, 2023 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On September 15, 2022, Mr. Pacelli adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Pacelli. The shares set forth above were sold pursuant to the 10b5-1 Plan that was intended to comply with prior version of Rule 10b5-1 promulgated under the Securities Exchange Act of 1934, as amended.
F2 Included in this number are 39,132 unvested restricted stock units, 18,776 of which were granted on March 8, 2023 and shall vest through March 8, 2026, 13,288 of which were granted on March 8, 2022 and shall vest through March 8, 2025, 7,068 of which were granted on March 8, 2021 and shall vest through March 8, 2024.